Editorial Comment to Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study.
Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. lara.bellardita@istitutotumori.mi.it.
Lara
L
Bellardita
Tiziana
T
Rancati
Riccardo
R
Valdagni
D000726:Androgen Antagonists / Q000627:therapeutic use*; D059186:Chemoradiotherapy, Adjuvant / Q000379:methods*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000473:pathology* / Q000628:therapy*; D011788:Quality of Life
D000726:Androgen Antagonists